Response: Sodium-Glucose Cotransporter-2 Inhibitors and Risk of Diabetic Ketoacidosis Among Adults With Type 2 Diabetes: A Systematic Review and Meta-Analysis

Can J Diabetes. 2022 Mar;46(2):110. doi: 10.1016/j.jcjd.2021.10.003. Epub 2021 Oct 22.

Authors

Michael Colacci¹, Michael Fralick¹

Affiliation

¹ Sinai Health System and Department of Medicine, University of Toronto, Toronto, Ontario, Canada; Department of Medicine, General Internal Medicine, University of Toronto, Toronto, Ontario, Canada.

PMID: 35181220
DOI: 10.1016/j.jcjd.2021.10.003

No abstract available

Publication types

Letter
Comment

MeSH terms

Adult
Diabetes Mellitus, Type 2* / complications
Diabetes Mellitus, Type 2* / drug therapy
Diabetic Ketoacidosis* / chemically induced
Diabetic Ketoacidosis* / epidemiology
Glucose
Humans
Sodium
Sodium-Glucose Transporter 2 Inhibitors* / adverse effects

Substances

Sodium-Glucose Transporter 2 Inhibitors
Sodium
Glucose